The 20 Best Severe Acute Respiratory Syndrome (SARS) Doctors Near Me in Ypsilanti, MI

Bing Xue is an Intensive Care Medicine provider practicing medicine in Ypsilanti, Michigan. Dr. Xue is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, Obstructive Sleep Apnea, Lung Metastases, Islet Cell Transplantation, and Gastrostomy.

Dr. Lauring received a PhD in molecular biology in 2000, followed by an MD in 2002, both from the University of Washington. He did his graduate work on retroviral pathogenesis at the Fred Hutchinson Cancer Research Center. Dr. Lauring completed a medical residency and infectious diseases fellowship at UCSF., where he also served as Chief Medical Resident. He joined the faculty at the University of Michigan Medical School in August 2012 and runs a research laboratory focused on virus evolution. Dr. Lauring is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Flu, Severe Acute Respiratory Syndrome (SARS), COVID-19, and Parainfluenza.

Dr. Hallie Prescott is an Associate Professor in Pulmonary & Critical Care Medicine at the University of Michigan and a staff physician the Ann Arbor Veterans Affairs Healthcare System. She completed pulmonary/critical care fellowship training in 2014 and currently attends in the Ann Arbor VA outpatient pulmonary clinic and medical intensive care unit, as well as the Critical Care Medicine Unit at Michigan Medicine. She has a master’s degree in healthcare research, with broad methodological expertise in quantitative, qualitative, and survey research methods. Her research program has leveraged nationwide Veterans Health Administration (VHA) data to answer clinically-important and policy-relevant questions. The primary focus of her research has been on sepsis care and outcomes. She serves as co-chair of the international Surviving Sepsis Campaign Guidelines and as lead for the Michigan Hospital Medicine Safety Consortium’s Sepsis Initiative. In addition to research on sepsis, Dr. Prescott has leveraged her clinical and methodological expertise to study a variety of topics, including hospital performance measurement and risk-adjustment methodology, COVID-19, VHA medication prescribing patterns, and interventional pulmonary procedures, among other topics. Her research contributions have been recognized by awards from American Thoracic Society, American Society of Clinical Innovation, Australia/New Zealand Intensive Care Society, and the Carol A. Kauffman MD Department of Internal Medicine Early Career Endowment Award (2019-2024) from the University of Michigan. Dr. Prescott is rated as an Advanced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), Pneumonia, COVID-19, Endoscopy, and Gastrostomy. Dr. Prescott is board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine.

Elizabeth Viglianti is an Internal Medicine specialist and a Pulmonary Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Viglianti is rated as an Advanced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), Long Haul COVID, COVID-19, and Acute Interstitial Pneumonia. Dr. Viglianti is board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine.

Anurag Malani is an Infectious Disease provider practicing medicine in Ypsilanti, Michigan. Dr. Malani is rated as an Advanced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Asymptomatic Bacteriuria, Pneumonia, Arachnoiditis, and Sporotrichosis.

Dr. Grace Jenq received her medical degree from Johns Hopkins University. She completed her residency and chief residency in internal medicine at University of Alabama Birmingham. She continued her fellowship training in Geriatrics at Yale University and stayed on faculty from 2005-2016. At Yale-New Haven Hospital she served as the Associate Chair for Patient Safety and Quality and the Medical Director for Inpatient Medicine. In 2016, she joined the University of Michigan Division of Geriatrics and Palliative Care Medicine. She is now a Professor in the Division of Geriatrics and Palliative Care Medicine at University of Michigan and the Associate Chief Clinical Officer for Post-Acute Care at Michigan Medicine. She cares for patients in the Michigan House Calls Program, Patient Monitoring at Home Program and the newly established Hospital Care at Home Program. She is also the program director for I-MPACT (Integrated Michigan Patient-Centered Alliance for Care Transitions) a Blue Cross Blue Shield of Michigan Collaborative Quality Initiative. Her quality improvement and academic interests lie in how to create better models to care for elderly persons within their own homes and how to enhance transitions of care out of the hospital by engaging clinicians and patients/caregivers and improving system design. In the Department of Medicine, she is a member of the Clinical Excellence Society and she received the Chairperson’s IMPACT Award in 2021.Published ArticlesMontoya A, Jenq GY, Mills JP, Beal J, Diviney Chun E, Newton D, Gibson K, Mantey J, Hurst K, Jones K,Mody L: Partnering with Local Hospitals and Public Health to Manage COVID-19 Outbreaks in NursingHomes J Am Geriatr Soc 69(1): 30-36, 2020. PMC7675453Renee Fekieta, PhD, MAa, Alana Rosenberg MPHb, Jenq GY, MDc, Beth L. Emerson, MD: A New Toolto Assess Clinician Experience with Patient Care Transitions Quality Management in Health Care 30(2):87-96, 2021.Peres-da-Silva, Ashwin, Vijayasari, Ganga, Hendee, Karly, Okammor, Nkiru, Jenq, GY, Bozaan, Dave:Reduction in Readmission Rates for COPD Patients with 7-day Post Hospital Follow-up Journal ofPulmonary and Respiratory Medicine 11(4): open access, 2021. Dr. Jenq is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). Her clinical expertise encompasses Heart Failure, Pulmonary Edema, Heart Failure with Preserved Ejection Fraction (HFpEF), and COVID-19.

Dr. Sjoding is a member of the Division of Pulmonary and Critical Care at the University of Michigan. He received a degree in Biochemistry from Valparaiso University in Indiana, and a medical degree from Loyola Stritch School of Medicine in Chicago. He completed his internal medicine residency at the University of Chicago.Dr. Sjoding’s health services research interests concern pulmonary and critical care and hospital medicine, with a focus on inpatient hospital quality measures and their unintended consequences, the epidemiology of critical illness, and methods for critical care delivery. He is also interested in leveraging “Big Data” to enhance critical care research and care, and health service research methods including the use of both clinical and large-scale administrative databases, statistical simulation, causal analysis, and multi-level modeling. Dr. Sjoding is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Acute Respiratory Distress Syndrome (ARDS), Cerebral Hypoxia, Chronic Obstructive Pulmonary Disease (COPD), and Pneumonia.

Dr. Valley is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine in the Department of Medicine at the University of Michigan. He received his undergraduate degrees in history and chemistry from Emory University, and his medical degree from the University of Miami. He completed his internal medicine residency at the University of Texas-Southwestern/Parkland Memorial Hospital, where he also served as Chief Medical Resident. He completed a fellowship in pulmonary and critical care medicine at the University of Michigan in 2016. During his fellowship, he earned a Masters of Health and Healthcare Research from the University of Michigan.Clinically, Dr. Valley focuses on the care of critically ill patients and their families. He practices in the Critical Care Medicine Unit at the University of Michigan and the Medical Intensive Care Unit at the Ann Arbor VA. He is the Director of the Ann Arbor VA's Post-ICU Survivor Care, Evaluation, and Support (PISCES) Clinic.Dr. Valley's research seeks to improve the delivery of care within ICUs. Currently, he has two broad research focuses: reducing disparities in ICU care among rural and minoritized communities and ensuring that ICU care is centered around patients and families. His work has been supported by the NIH/NHLBI, the Agency for Healthcare Research and Quality, and the VA Health Services Research and Development Service. Dr. Valley is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses COVID-19, Pneumonia, Systemic Sclerosis (SSc), and Cerebral Hypoxia.

Sara Mirza is an Internal Medicine specialist and an Intensive Care Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Mirza is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Cerebral Hypoxia, Lung Metastases, Acute Respiratory Distress Syndrome (ARDS), Gastrostomy, and Bone Marrow Aspiration.

Dr. Dickson's laboratory specializes in integrative translational research, spanning from molecular characterization of respiratory microbiota to animal modeling of acute lung disease to prospective trials of human subjects. His work has been published in Nature Microbiology, The Lancet, the American Journal of Respiratory and Critical Care Medicine and Lancet Respiratory Medicine. He is an Associate Director of the Michigan Center for Integrative Research in Critical Care, a member of the Editorial Board of Lancet Respiratory Medicine, and an Associate Editor of Microbiome. Dr. Dickson is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Pneumonia, Acute Respiratory Distress Syndrome (ARDS), Acute Interstitial Pneumonia, Lung Transplant, and Endoscopy. Dr. Dickson is board certified in Pulmonary Disease and Critical Care Medicine.

Jakob Mcsparron is an Internal Medicine specialist and an Intensive Care Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Mcsparron is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Cerebral Hypoxia, Acute Respiratory Distress Syndrome (ARDS), Pneumocystis Jiroveci Pneumonia, Endoscopy, and Liver Embolization. Dr. Mcsparron is board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine.

Dr. Hyzy is the Medical Director of the Critical Care Medicine Unit and Co-Chair of the Critical Care Committee at the University of Michigan Hospital. Dr. Hyzy is a graduate of Kenyon College and NYU School of Medicine and trained in Internal Medicine and Pulmonary and Critical Care Medicine at the University of Michigan. Dr. Hyzy’s research interest in thin the intensive care unit including patients with the Acute Respiratory Distress Syndrome, sepsis and respiratory failure. In the Pulmonary Clinic he participated as a Co-Investigator in clinical trials in patients with Idiopathic Pulmonary Fibrosis and COPD. Dr. Hyzy is an active clinician and researcher with multiple publications including serving as editor of a critical care textbook published by Springer and 14 topics to the online medical reference UpToDate. Dr. Hyzy is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Pneumonia, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Idiopathic Pulmonary Fibrosis.

Dr. De Cardenas is the Director of the Interventional Pulmonology Program at the University of Michigan and a Clinical Associate Professor of Medicine and Surgery. He is part of the multidisciplinary team at the University of Michigan that treats patients with complex airway and pleural diseases. He has specific expertise in minimally invasive advanced diagnostic and therapeutic bronchoscopic and pleural procedures, critical care ultrasonography and medical education. His academic interests include endobronchial device development for treatment of early lung cancer, pleural infectious diseases, and developing novel methods to teach procedural skills.Honors and Awards:2017 Nominee Emerging Educator Award - Association of Pulmonary and Critical Care Medicine Program Directors (APCCMPD)2014 Fellow of the Year, Department of Medicine. Zucker School of Medicine at Hofstra Northwell, NY2012 Best Teaching Senior Resident, Leo M. Davidoff Society Awards, Albert Einstein College of Medicine2011 Best Teaching Junior Resident, Leo M. Davidoff Society Awards, Albert Einstein College of Medicine2010 Best Teaching Intern, Leo M. Davidoff Society Awards, Albert Einstein College of MedicineCredentials:Medical SchoolMD, Facultad de Medicina. Universidad Nacional de Trujillo, Peru 2006ResidencyAlbert Einstein College of Medicine, Jacobi Medical Center, Internal Medicine, NY 2012FellowshipsHarvard Medical School, Combined Interventional Pulmonology Fellowship. Beth Israel Deaconess Medical and Massachusetts General Hospital, Boston, MA, 2016Zucker School of Medicine. Pulmonary and Critical Care Medicine, North Shore University Hospital and Long Island Jewish Medical Center, NY 2015Board Certifications2012: Board Certification in Internal Medicine2014: Board Certification in Pulmonary Medicine2016: Board Certification in Critical Care Medicine2017: Board Certification in Interventional Pulmonology. AABIP. Dr. De Cardenas is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Advanced Bronchoscopy, and Endoscopy. Dr. De Cardenas is board certified in Pulmonary Disease, Critical Care Medicine, and Interventional Pulmonology.

Leigh Cagino is a Pulmonary Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Cagino is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). Her clinical expertise encompasses Lung Metastases, Acute Interstitial Pneumonia, Sarcoidosis, and Neurosarcoidosis. Dr. Cagino is board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine.

Dr. Benjamin Singer is an Assistant Professor in Pulmonary and Critical Care Medicine in the Department of Internal Medicine at the University of Michigan. He received his undergraduate degree in mathematics at the University of Michigan in 2002. Dr. Singer completed his medical training and PhD in Neuroscience through the Medical Scientist Training Program, and subsequently completed residency in Internal Medicine and fellowship training in Pulmonary and Critical Care Medicine, all at the University of Michigan.Approximately half of patients who survive an episode of critical illness experience long term brain dysfunction, in the form of anxiety, depression, post traumatic stress, or cognitive impairment. Dr. Singer’s research focuses on basic and translational studies of long-term brain injury after critical illness, with a focus on sepsis. These studies utilize animal models of sepsis and patient autopsy specimens to examine the immune and vascular responses to sepsis in the brain that persist for weeks to months after the outward signs of illness have resolved. In collaboration with Dr. Bob Dickson, he also examines the role of the gut microbiome in initiation of brain injury and multiorgan failure during sepsis. The goal of this work is to identify strategies to minimize and rehabilitate ongoing brain injury in sepsis survivors. Areas of special clinical focus include the care of patients with advance neuromuscular disease requiring chronic assisted ventilation. Dr. Singer is supported by a National Institute of Neurological Disorders and Stroke Career Development Award, MICHR, and University of Michigan Depression Center. Dr. Singer is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Lung Metastases, Acute Interstitial Pneumonia, Obesity Hypoventilation Syndrome (OHS), and Interstitial Lung Disease. Dr. Singer is board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine.

Mohammad Salameh is a primary care provider, practicing in Internal Medicine in Ypsilanti, Michigan. Dr. Salameh is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His clinical expertise encompasses Macrosomia, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Lymphofollicular Hyperplasia.

Susan Hickenbottom is a Palliative Medicine provider practicing medicine in Ypsilanti, Michigan. Dr. Hickenbottom is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). Her clinical expertise encompasses Stroke, Transient Ischemic Attack (TIA), Seizures, and Primary Progressive Aphasia.

Preeti N. Malani, MD, MSJ is a Professor of Medicine in the Division of Infectious Diseases and a Special Advisor to the President. In addition, Dr. Malani is Deputy Editor and Director of Editorial Equity for JAMA and the JAMA Network. From 2017 to 2022, she served as the University of Michigan’s Chief Health Officer. As Chief Health Officer, Dr. Malani worked with dozens of individuals committed to advancing health across campus, often taking an academic lens to the role employers can play in improving health equity. During the pandemic, Governor Gretchen Whitmer appointed Dr. Malani to the state’s COVID-19 Nursing Home Task Force. She also served on the National Institutes of Health’s Data Safety and Monitoring Board for Operation Warp Speed. Dr. Malani is a member of the research team that oversees the National Poll on Healthy Aging (NPHA) based at the Institute for Healthcare Policy and Innovation (IHPI), serving as the poll’s inaugural director from 2016-2022.Dr. Malani is a graduate of the University of Michigan. She received her MD degree from Wayne State University School of Medicine. Prior to medical school, she completed a master’s degree in journalism at Northwestern University’s Medill School of Journalism. She completed her internal medicine residency and infectious diseases fellowship at the University of Michigan where she also received a master’s degree in clinical research design and statistical analysis. Dr. Malani completed fellowship training in geriatric medicine at the Oregon Health and Science University. Dr. Malani is rated as an Advanced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Monkeypox, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Sepsis. Dr. Malani is board certified in Infectious Disease.

Peter Mourani is a Pediatrics specialist and a Pediatric Pulmonologist practicing medicine in Ann Arbor, Michigan. Dr. Mourani is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Bronchopulmonary Dysplasia, Premature Infant, High Blood Pressure in Infants, and Acute Respiratory Distress Syndrome (ARDS). Dr. Mourani is board certified in Pediatric Pulmonology and Pediatric Critical Care Medicine.

Dr. Mody is one of very few internists in this country with an expertise in aging populations, epidemiology, an active research laboratory in microbiology and a translational research agenda focused on vulnerable aging population. She has mentored several junior faculty, fellows, post-doctoral students and residents in conducting clinical, epidemiologic as well as laboratory-based research projects and has had uninterrupted NIH funding since 2003. In 2015, she received a 5-year NIH K24 Midcareer Investigator Award to mentor junior faculty in translational aging, infectious diseases and health outcomes research. Her NIH and AHRQ funded work has created a thriving consortium of post-acute and long-term care facilities in SE Michigan interested in developing interventions to enhance infection prevention in a traditionally resource poor setting. In an NIH-R01 study (PI: Mody), her team evaluated a multi-modal targeted infection-prevention (TIP) intervention to prevent resistant organisms and infections in long-term care residents with indwelling devices. This study has garnered national attention and spurred several subsequent pilot projects. Our group (PIs: Saint, Mody) has been awarded an AHRQ contract to implement lessons learnt from this model to 500 federal and non-federal post-acute and long-term care facilities across 50 states in the US. Funded by another concurrent NIH-R01 (PI: Mody), her team is defining the complex relationship between antimicrobial resistance, caregiver and environmental contamination, and functional disability in post-acute care facilities. In order to understand transmission dynamics within post-acute and long-term care facilities, she is collaborating with other national leaders to evaluate spread of organisms from a resident to healthcare worker gown and gloves. She is nationally active at several research methodology and career development activities at the American Geriatrics Society, Society for Healthcare Epidemiology of America and the Infectious Diseases Society of America. Dr. Mody is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Methicillin-Resistant Staphylococcus Aureus (MRSA), Urinary Tract Infection (UTI), Asymptomatic Bacteriuria, Severe Acute Respiratory Syndrome (SARS), and Hormone Replacement Therapy (HRT).